|
|
Volumn 12, Issue 17, 2002, Pages 2427-2430
|
|
Quinoline-3-carbothioamides and related compounds as novel immunomodulating agents
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
FR 165009;
IMMUNOMODULATING AGENT;
LIPOPOLYSACCHARIDE;
QUINOLINE DERIVATIVE;
THIOAMIDE;
UNCLASSIFIED DRUG;
IMMUNOLOGICAL ADJUVANT;
QUINOLINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBODY PRODUCTION;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SYNTHESIS;
GRAFT VERSUS HOST REACTION;
IMMUNIZATION;
IMMUNOREACTIVITY;
MOUSE;
NEPHROSIS;
NONHUMAN;
ANIMAL;
DISEASE MODEL;
DOG;
HALF LIFE TIME;
NEPHRITIS;
ORAL DRUG ADMINISTRATION;
PROTEINURIA;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIBODY FORMATION;
AUTOIMMUNE DISEASES;
DISEASE MODELS, ANIMAL;
DOGS;
GRAFT VS HOST DISEASE;
HALF-LIFE;
IMMUNIZATION;
MICE;
NEPHRITIS;
PROTEINURIA;
QUINOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIOAMIDES;
|
|
EID: 0037009276
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00377-3 Document Type: Article |
|
Times cited : (24)
|
|
References (21)
|
